Article

Phakic IOL delivers good results in FDA trial for myopia

Anaheim, CA-An increasing number of IOLs are being developed to achieve improved vision in patients with extreme levels of myopia. One such lens is the Artisan/ Verisyse phakic IOL (Ophtec USA/Advanced Medical Optics), said R. Doyle Stulting, MD, PhD, who reported the results of the FDA clinical study here at the American Academy of Ophthalmology annual meeting.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
© 2024 MJH Life Sciences

All rights reserved.